Literature DB >> 24735419

Translational research investigations on ATP7A: an important human copper ATPase.

Stephen G Kaler1.   

Abstract

In more than 40 years since copper deficiency was delineated in pediatric subjects with Menkes disease, remarkable advances in our understanding of the clinical, biochemical, and molecular aspects of the human copper transporter ATP7A have emerged. Mutations in the gene encoding this multitasking molecule are now implicated in at least two other distinctive phenotypes: occipital horn syndrome and ATP7A-related isolated distal motor neuropathy. Several other novel inherited disorders of copper metabolism have been identified in the past several years, aided by advances in human gene mapping and automated DNA sequencing. In this paper, I review the history and evolution of our understanding of disorders caused by impaired ATP7A function, and outline future challenges. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  ATP7A; Menkes disease; human copper metabolism; occipital horn syndrome; viral gene therapy

Mesh:

Substances:

Year:  2014        PMID: 24735419      PMCID: PMC4095951          DOI: 10.1111/nyas.12422

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A.

Authors:  Ling Yi; Stephen Kaler
Journal:  Ann N Y Acad Sci       Date:  2014-04-22       Impact factor: 5.691

Review 2.  Inborn errors of copper metabolism.

Authors:  Stephen G Kaler
Journal:  Handb Clin Neurol       Date:  2013

3.  Altered intracellular localization and valosin-containing protein (p97 VCP) interaction underlie ATP7A-related distal motor neuropathy.

Authors:  Ling Yi; Anthony Donsante; Marina L Kennerson; Julian F B Mercer; James Y Garbern; Stephen G Kaler
Journal:  Hum Mol Genet       Date:  2011-12-30       Impact factor: 6.150

4.  Menkes' kinky-hair syndrome.

Authors:  D M Danks; P E Campbell; J Walker-Smith; B J Stevens; J M Gillespie; J Blomfield; B Turner
Journal:  Lancet       Date:  1972-05-20       Impact factor: 79.321

5.  Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease.

Authors:  S G Kaler; D S Goldstein; C Holmes; J A Salerno; W A Gahl
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

6.  Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein.

Authors:  J Chelly; Z Tümer; T Tønnesen; A Petterson; Y Ishikawa-Brush; N Tommerup; N Horn; A P Monaco
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

7.  L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model.

Authors:  Anthony Donsante; Patricia Sullivan; David S Goldstein; Lauren R Brinster; Stephen G Kaler
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Gastrointestinal hemorrhage associated with gastric polyps in Menkes disease.

Authors:  S G Kaler; J A Westman; S M Bernes; A M Elsayed; C M Bowe; K L Freeman; C D Wu; M T Wallach
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

9.  Menkes' syndrome: ophthalmic findings.

Authors:  Alice T Gasch; Rafael C Caruso; Stephen G Kaler; Muriel Kaiser-Kupfer
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

10.  Increased frequency of congenital heart defects in Menkes disease.

Authors:  Julia D Hicks; Anthony Donsante; Tyler M Pierson; Matthew J Gillespie; Denise E Chou; Stephen G Kaler
Journal:  Clin Dysmorphol       Date:  2012-04       Impact factor: 0.884

View more
  8 in total

Review 1.  Copper suppression as cancer therapy: the rationale for copper chelating agents in BRAFV600 mutated melanoma.

Authors:  Sarah Sammons; Donita Brady; Linda Vahdat; April Ks Salama
Journal:  Melanoma Manag       Date:  2016-09-02

2.  Multimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease.

Authors:  Cheri M Ackerman; Peter K Weber; Tong Xiao; Bao Thai; Tiffani J Kuo; Emily Zhang; Jennifer Pett-Ridge; Christopher J Chang
Journal:  Metallomics       Date:  2018-03-06       Impact factor: 4.526

3.  Copper chaperone ATOX1 is required for MAPK signaling and growth in BRAF mutation-positive melanoma.

Authors:  Ye-Jin Kim; Gavin J Bond; Tiffany Tsang; Jessica M Posimo; Luca Busino; Donita C Brady
Journal:  Metallomics       Date:  2019-07-18       Impact factor: 4.526

4.  Endogenous concentrations of biologically relevant metals in rat brain and cochlea determined by inductively coupled plasma mass spectrometry.

Authors:  Stacia R Wegst-Uhrich; Elizabeth J Mullin; Dalian Ding; Senthilvelan Manohar; Richard Salvi; Diana S Aga; Jerome A Roth
Journal:  Biometals       Date:  2014-12-24       Impact factor: 3.378

5.  TAp73 regulates ATP7A: possible implications for ageing-related diseases.

Authors:  Piervito Lopriore; Nazzareno Capitanio; Emanuele Panatta; Nicola Di Daniele; Alessandra Gambacurta; Gerry Melino; Ivano Amelio
Journal:  Aging (Albany NY)       Date:  2018-12-08       Impact factor: 5.682

Review 6.  COMMD1 Exemplifies the Power of Inbred Dogs to Dissect Genetic Causes of Rare Copper-Related Disorders.

Authors:  Ronald Jan Corbee; Louis C Penning
Journal:  Animals (Basel)       Date:  2021-02-25       Impact factor: 2.752

Review 7.  Bioavailable Trace Metals in Neurological Diseases.

Authors:  Aurélia Poujois; Jean-Christophe Devedjian; Caroline Moreau; David Devos; Pascal Chaine; France Woimant; James A Duce
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

Review 8.  Copper metabolism as a unique vulnerability in cancer.

Authors:  Vinit C Shanbhag; Nikita Gudekar; Kimberly Jasmer; Christos Papageorgiou; Kamal Singh; Michael J Petris
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-10-20       Impact factor: 4.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.